IFNA1 and systemic lupus erythematosus: The abovementioned results all confirm that the injection of Adv-IFN-α in NZB/NZW F1 mice accelerated the main clinical symptoms of SLE and resulted in corresponding inflammation in the brain and kidneys of mice, suggesting that it activated autoimmune status.